Clinical Trial Update: A Open-label Study to Evaluate the Relative Bioavailability of Samatasvir (IDX184) and Food Effect in Healthy Male Participants (MK-2355-006) [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 open-label study to compare the relative bioavailability of Samatasvir (IDX184) and assess the ef…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Samatasvir (samatasvir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED